AI-generated summary
The authors report a clinical study of photodynamic therapy with a chlorine-e6 photosensitizer and 660 nm laser light in 23 patients with 44 oral leukoplakia lesions. Lesion size fell by an average of 53.8%, with 12 lesions completely cured and 22 partially cured, and no adverse site effects were noted. The authors state that the small number of cases and the need for longer follow-up limit the conclusions.
- Participants
- 23
- Who or what was studied
- Patients with oral leukoplakia (aged 21-79) with 44 histopathologically confirmed lesions
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The authors note the study is limited by its small number of cases and short follow-up, and that larger, longer studies are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660nm
- Power
- 300mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photodynamic therapy, Wavelength, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.